Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ProPhase Labs (PRPH) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for ProPhase Labs (PRPH) over the last 15 years, with Q3 2025 value amounting to 20.92%.

  • ProPhase Labs' Return on Capital Employed rose 214200.0% to 20.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.92%, marking a year-over-year increase of 214200.0%. This contributed to the annual value of 0.85% for FY2024, which is 5400.0% down from last year.
  • Per ProPhase Labs' latest filing, its Return on Capital Employed stood at 20.92% for Q3 2025, which was up 214200.0% from 1.53% recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' Return on Capital Employed registered a high of 20.92% during Q3 2025, and its lowest value of 1.53% during Q2 2025.
  • For the 5-year period, ProPhase Labs' Return on Capital Employed averaged around 0.91%, with its median value being 0.07% (2021).
  • Data for ProPhase Labs' Return on Capital Employed shows a peak YoY increase of 214200bps (in 2025) and a maximum YoY decrease of -10300bps (in 2025) over the last 5 years.
  • ProPhase Labs' Return on Capital Employed (Quarter) stood at 0.15% in 2021, then soared by 105bps to 0.31% in 2022, then plummeted by -197bps to 0.3% in 2023, then tumbled by -185bps to 0.85% in 2024, then soared by 2557bps to 20.92% in 2025.
  • Its Return on Capital Employed was 20.92% in Q3 2025, compared to 1.53% in Q2 2025 and 1.06% in Q1 2025.